STOCK TITAN
  1. Home
  2. Sec-filings
  3. KPTI
  4. [SCHEDULE 13G] Karyopharm Therapeutics Inc. SEC Filing

[SCHEDULE 13G] Karyopharm Therapeutics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock KPTI logo
Karyopharm Therapeutics Inc

NASDAQ:KPTI

KPTI Rankings

#7562 Ranked by Market Cap
N/A Ranked by Dividends

KPTI Latest News

Jul 1, 2025
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 3, 2025
Karyopharm to Present at the Jefferies Global Healthcare Conference
Jun 2, 2025
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2025
Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference
May 14, 2025
Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting

KPTI Latest SEC Filings

Jul 11, 2025
[8-K] Karyopharm Therapeutics Inc. Reports Material Event

KPTI Stock Data

41.56M
8.09M
6.86%
48.47%
12.56%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWTON